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ABSTRACT
Background: Self-diagnosis of inﬂuenza is an
important component of pandemic control and
management as it may support self-management
practices and reduce visits to healthcare facilities, thus
helping contain viral spread. However, little is known
about the accuracy of self-diagnosis of inﬂuenza,
particularly during pandemics.
Methods: We used cross-sectional survey data to
correlate self-diagnosis of inﬂuenza with serological
evidence of 2009 pandemic inﬂuenza A(H1N1) infection
(haemagglutination inhibition titres of $1:40) and to
d e t e r m i n ew h a ts y m p t o m sw e r em o r el i k e l yt ob ep r e s e n t
in accurate self-diagnosis. The sera and risk factor data
were collected for the national A(H1N1) seroprevalence
survey from November 2009 to March 2010, 3 months
after the ﬁrst pandemic wave in New Zealand (NZ).
Results: The samples consisted of 318 children, 413
adults and 423 healthcare workers. The likelihood of
being seropositive was no different in those who believed
they had inﬂuenza from those who believed they did not
have inﬂuenza in all groups. Among adults, 23.3% (95%
CI 11.9% to 34.7%) of those who reported having had
inﬂuenza were seropositive for H1N1, but among those
reporting no inﬂuenza, 21.3% (95% CI 13% to 29.7%)
were also seropositive. Those meeting NZ surveillance or
Ministry of Health inﬂuenza case deﬁnitions were more
likely to believe they had the ﬂu (surveillance data adult
sample OR 27.1, 95% CI 13.6 to 53.6), but these
symptom proﬁles were not associated with a higher
likelihood of H1N1 seropositivity (surveillance data adult
sample OR 0.93, 95% CI 0.5 to 1.7).
Conclusions: Self-diagnosis does not accurately
predict inﬂuenza seropositivity. The symptoms
promoted by many public health campaigns are linked
with self-diagnosis of inﬂuenza but not with
seropositivity. These ﬁndings raise challenges for
public health initiatives that depend on accurate self-
diagnosis by members of the public and appropriate
self-management action.
BACKGROUND
Self-diagnosis is an important component of
pandemic control and management. The use
of self-diagnosis in an inﬂuenza pandemic
can prevent some exposures by reducing
outpatient visits to primary care clinics.
1
During the 2009 pandemic, following
Centers for Disease Control recommenda-
tions, patient teaching brochures advised
patients to stay at home and avoid contact
with other people if they had inﬂuenza like
illness (ILI), seeking medical assistance only
in case of complications or risk factors. While
the accuracy of self-diagnosis has been
studied for a range of common diseases (eg,
uncomplicated urinary tract infections,
23
vaginal yeast infections
4 and malaria
56 ), it
has not been established for inﬂuenza.
Although self-diagnosis of inﬂuenza is
clearly desirable for the purposes of infection
containment, it also presents challenges for
patients and doctors alike. As the social
science literature clearly articulates, diagnosis
is central to the practice of medicine and to
deﬁning the roles of, and boundaries
between, the patient and the professional;
however, self-diagnosis blurs these
distinctions.
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ARTICLE SUMMARY
Article focus
- To determine whether lay people can accurately
recognise inﬂuenza infection.
Key messages
- Individuals meeting inﬂuenza case deﬁnitions
were more likely to believe they had inﬂuenza.
- Self-diagnosis, whether by a lay person or
a healthcare worker, did not accurately predict
inﬂuenza seropositivity.
Strengths and limitations of this study
- This is the ﬁrst published study of the effective-
ness of self-diagnosis of inﬂuenza compared with
laboratory evidence of infection in a broad
population-based sample during a pandemic.
- Some of the participants who believed they had
the ﬂu may have had a seasonal inﬂuenza or
other respiratory pathogens (although H1N1 was
the dominant inﬂuenza strain).
- This survey was based on symptom recall rather
than symptom reports, which may reﬂect the
participants’ enduring perceptions of inﬂuenza,
likely to guide their behaviour in future inﬂuenza
epidemics.
Jutel A, Baker MG, Stanley J, et al. BMJ Open 2011;2:e000234. doi:10.1136/bmjopen-2011-000234 1
Open Access ResearchThe diagnosis of inﬂuenza by a lay person may be
independent of medical contact, using resources such as
family, friends or other non-medical sources of infor-
mation, for example on-line or internet resources
(independent self-diagnosis). It may also be supported
by a health professional via a helpline without the
lay person being seen for a clinical diagnosis (assisted
self-diagnosis).
The purpose of this study was to determine whether
lay people’s assessment of inﬂuenza status is conﬁrmed
by serological testing, and whether the presence of
particular symptoms assists individuals in the correct
identiﬁcation of inﬂuenza. It also aimed to measure the
accuracy of self-diagnosis by healthcare workers (HCW).
Establishing the current reliability of self-diagnosis will
either provide assurances about, or identify shortcom-
ings in, public health strategies to contain the spread of
inﬂuenza.
METHODS
Population sample
This study was conducted as part of the national Envi-
ronmental Science and Research (ESR) seroprevalance
study in early 2010.
11 This study used a purposive, multi-
stage random cross-sectional survey of 1147 subjects
from selected primary care patient registers from 14
general practitioner (GP) practices. The practices were
selected purposively on the basis of observed high,
medium and low incidence during the pandemic and on
ethnic distribution. Each practice was stratiﬁed by age
and by ethnic group. Within each stratum, simple
random sampling was undertaken, with oversampling in
strata for M aori and Paciﬁc respondents to improve the
precision of estimates for these groups. A second sample
consisted of 540 HCW (369 HCW located in Auckland
and Middlemore Hospitals, and 171 from the 14 GP
practices in the community study). The HCW sample
included medical, nursing and other staff. A simple
random sampling procedure was performed to select
participants for this sample.
11 Sera and risk factor data
were collected from November 2009 to March 2010,
3 months after the ﬁrst pandemic wave in New Zealand
(NZ).
12 Ethics approval (MEC/09/09/106) was
obtained from the Multiregional Ethics Committee of
the NZ Ministry of Health. Written informed consent was
obtained from all participants.
11
We excluded participants born before 1957 because of
the higher level of pre-pandemic seropositivity in this
group.
11 We treated those under age 18 as a separate
group because their questionnaires were usually
completed by parents (self-diagnosis by proxy) and their
health-related behaviours were likely inﬂuenced or, for
the very young, entirely managed by their parents.
We also considered HCW separately from lay partici-
pants; however, as the sampling methods for this group
were different from the main community sample (the
geographical area was more restricted in the HCW
sample), comparisons between this group and the adult
community sample should be made with caution.
Laboratory testing
Blood samples were obtained by phlebotomists in the GP
clinics, and serological testing was carried out at the
National Inﬂuenza Centre at ESR using a haemaggluti-
nation inhibition assay in line with the standard protocol
provided by the WHO Collaborating Centre in
Melbourne. Haemagglutination inhibition titres of $40
against H1N1 were considered seroprotective as well as
seropositive. Laboratory testing methods are fully
described elsewhere.
11
Questionnaire
A questionnaire was administered by nurses from 14
participating GP clinics at the time of the blood sample
collection in order to record information about
respondent demographics, whether respondents
believed they had contracted inﬂuenza in 2009 and their
symptoms. Questions were both multiple-choice and
open-ended.
Respondents were asked ‘Did you have the ﬂu or
inﬂuenza over this last winter (June to August)?’, with
options being ‘yes’, ‘possibly’, ‘no’ and ‘don’t know’.
Those who believed they had had inﬂuenza were asked
how they knew, choosing either:
1. I could tell on my own or with the help of my family
and friends
2. I called the nurse or HealthLine and they helped me
to decide, or
3. I saw my doctor or other health professional who told
me I did.
Self-diagnosis was deﬁned as including both indepen-
dent and assisted forms (ie, choosing 1 or 2 above) for
those who responded ‘yes’ to the question about having
had inﬂuenza.
Two additional case deﬁnitions of inﬂuenza were used
based on reported symptoms: ILI deﬁned by the NZ
sentinel surveillance deﬁnition
13 of two or more symp-
toms from fever, muscle ache and headache (reports of
chills are included in this deﬁnition, but this informa-
tion was not collected in this study) and also by the NZ
Ministry of Health
14 as fever, plus cough or sore throat
(reports of chills or sweating are included in this deﬁ-
nition, but this information was not collected in the
study).
Demographic information included age, gender, self-
identiﬁed ethnicity and socioeconomic deprivation
(using NZDep, a well-validated measure of small-area
socioeconomic deprivation based on census-derived
characteristics such as income, education and household
crowding, and assigned according to domicile
address
15). Ethnicity classiﬁcation used the NZ 2006
Census questions, and prioritised ethnicity coding
according to Ministry of Health ethnicity data proto-
cols.
16 Participants could choose up to nine different
symptoms (fever or high temperature; cough; sore
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Self-diagnosis of inﬂuenzathroat; runny nose; red, watery or sore eye(s); headache;
muscle aches and pains; weakness, tiredness or fatigue;
an upset stomach, diarrhoea or vomiting, to describe any
illness they had during the period under study as well as
the open-ended ‘something else (describe)’.
Analysis
All statistical analyses were performed using SAS V.9.2.
Survey analysis techniques were used to take into
account differential sampling probabilities by age and
ethnicity; sample weights were calculated by ESR as the
inverse probability of selection of an individual within
each GP practice.
Proportions (and 95% CI) were calculated using the
Surveyfreq procedure, taking into account clustering by
GP practice and sample weight (as described above) for
the adult/child community samples. c
2 Comparisons for
the complex survey data (seroprevalence community
survey) were adjusted using the Rao-Scott correction
17 to
allow for the impact of the complex survey structure and
to test whether seropositivity rates were different
between the three self-reported inﬂuenza status groups,
and also to test whether seropositivity status differed
according to the decision making process by which
a respondent had decided that he or she (or their child)
had inﬂuenza. As the HCW dataset did not derive from
a complex sampling method, Pearson’s c
2 tests were
used for the equivalent hypothesis tests for that group.
Sensitivity and speciﬁcity (along with positive predic-
tive value (PPV) and negative predictive value (NPV))
were calculated for seropositive status as the ‘gold stan-
dard’ measure of disease status, and three deﬁnitions of
inﬂuenza ‘screening’ tests: self-report, Ministry of Health
case deﬁnition, and NZ sentinel surveillance case deﬁ-
nition. Self-reported inﬂuenza status was reclassiﬁed as
a binary variable by combining ‘deﬁnite’ and ‘possibly’
groups into a ‘positive self-report’ group for the
purposes of this analysis. We opted for this reconﬁgura-
tion because we felt it was the most policy-relevant
categorisation and would potentially translate into useful
health advice (either of these groups was likely to
implement inﬂuenza-related management strategies).
All of these calculations and CIs were performed using
the Proc Surveyfreq command.
Logistic regression methods (Proc Surveylogistic) were
used to investigate the relationships between case deﬁ-
nition status (separate models for the different deﬁni-
tions) and (1) self-reported inﬂuenza status or (2)
seropositive test results.
RESULTS
Characteristics of the sample
For the community branch of the study, a minimum
sample size of 1500 subjects was required at a design
prevalence of 20% and a conﬁdence level of 95% to
maintain a 610% margin error of estimate. A total of
1147 subjects participated fully in the study (nine did not
return the questionnaire and were thus excluded from
the analysis). This gave a target rate of 76%. For the
HCW branch of the study, the minimum sample size was
calculated using the same criteria as for the community
study. The number of subjects (171 primary HCW and
369 secondary HCW) exceeded the minimum require-
ment. Of the 1687 subjects with completed question-
naires and serological results across the community and
HCW studies, after excluding those respondents born
before 1957, 413 responses (unweighted frequency)
were considered for the analyses of adult responses. In
addition, 318 responses concerning children were
considered and 423 HCW responses. This gave a ﬁnal
sample size of 1154 people across the three groups.
The baseline demographic characteristics of the study
populations are shown in table 1. These are unweighted
frequencies and percentages; all subsequent analyses
take the sampling structure into account.
11 The sample
was not adequately powered to demonstrate ethnic
differences in the ﬁndings reported below.
Accuracy of self-report of inﬂuenza
Seropositivity status was compared across the three self-
reported inﬂuenza status groups (yes, no or possibly had
the ﬂu in 2009). Respondents who answered ‘don’t
know’ to this question (n¼16, 21 and 22 for adult, child
and HCW samples, respectively) were excluded from this
analysis. As shown in table 2, the likelihood of being
seropositive was not signiﬁcantly different between the
three self-reported inﬂuenza status groups in any of the
three sample groups. For adults in the community
sample, point estimates of seropositive status ranged
from 21.3% to 25.1% across the three self-report groups;
for under 18s in the same sample, seropositive rates were
between 40.1% and 45.9%, which was the highest among
all three sample groups; and for HCW, the range was
between 25.7% and 33.0% seropositive.
Table 3 shows that among those study subjects who
reported having had inﬂuenza, the proportion of people
who were seropositive was higher among those who
reached a decision in conjunction with a health profes-
sional than among those who reported reaching a diag-
nosis on their own (including using a telephone
helpline). While this pattern was consistent across all
three sample sources, none of these differences were
statistically signiﬁcant (all p>0.3), which possibly reﬂects
the smaller sample sizes for this analysis.
As shown in table 4, self-reported ﬂu status performed
poorly as a screening tool for H1N1 infection, failing to
detect the majority of those who were seropositive (adult
sensitivity 45.7%). Only about a quarter of those who
considered themselves to have had inﬂuenza during the
preceding winter showed serological evidence of infec-
tion (adult PPV 24.1%). Self-reported ﬂu status had
higher sensitivity and lower speciﬁcity than the Ministry
of Health and NZ sentinel surveillance case deﬁnitions.
Screening performance (sensitivity, speciﬁcity, PPV and
NPV) was otherwise broadly similar across the three sets
of ‘screening’ criteria used. PPV and NPV values across
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Self-diagnosis of inﬂuenzaall deﬁnitions followed the pattern seen for seropositive
prevalence (eg, children had the highest PPV, reﬂecting
a higher proportion of seropositive tests).
Seropositive status, symptom proﬁles and case deﬁnitions
of inﬂuenza
Using Ministry of Health and the NZ sentinel surveil-
lance ILI case deﬁnitions, we sought to conﬁrm whether
there was an increased likelihood of seropositivity for
those who met these case deﬁnitions, based on self-
report of symptoms. The likelihood of being seropositive
was not signiﬁcantly different between these symptom
proﬁle groups for any sample group (see table 5; 95%
CIs for all ORs included 1). People who met a case
deﬁnition had a much greater likelihood of self-
reporting having had inﬂuenza (table 5, for both
deﬁnitions).
DISCUSSION
Key ﬁndings
To our knowledge, this is the ﬁrst published study of the
effectiveness of self-diagnosis of inﬂuenza compared
with laboratory evidence of infection in a broad
Table 2 Serological status according to self-reported ﬂu status (proportions and 95% CI)
Self-reported ﬂu status n % Seropositive* 95% CI p Valuey
Adults (18+ years)z (n¼413)
No 221 21.3 13.0 to 29.7 0.802
Possibly 68 25.1 14.2 to 36
Yes 108 23.3 11.9 to 34.7
Children (<18 years)x (n¼318)
No 149 45.9 34.4 to 57.4 0.723
Possibly 55 42.2 28.6 to 55.9
Yes 86 40.1 24.7 to 55.6
Healthcare workers{ (n¼423)
No 222 25.7 20.1 to 31.9 0.415
Possibly 80 27.5 18.1 to 38.6
Yes 94 33.0 23.6 to 43.4
*Weighted percentage.
yp Values for adults and children in a community sample from the Rao-Scott c
2 test; p value for healthcare workers is from Pearson’s c
2 test.
z16 Adults from a community sample responded ‘don’t know’ on self-reported inﬂuenza status and were excluded from analysis.
x21 Children from a community sample responded ‘don’t know’ on self-reported inﬂuenza status and were excluded from analysis.
{22 Healthcare worker who responded ‘don’t know’ and ﬁve missing immunological status were excluded from analysis.
Table 1 Demographic characteristics of participants (unweighted frequencies and percentages)
Factor
Adults (18+ years) (n[413) Children (<18 years) (n[318) Healthcare workers (n[423)
Frequency Percentage* Frequency Percentage* Frequency Percentage*
Sex
Female 262 63.44 150 47.62 348 82.27
Male 151 36.56 165 52.38 75 17.73
Unknown 0 3 0
Ethnicity
NZEy 160 47.76 95 42.22 289 68.97
M aori 82 24.48 53 23.56 20 4.77
Paciﬁc 65 19.40 54 24.00 14 3.34
Asian 22 6.57 17 7.56 92 21.96
Other 6 1.79 6 2.67 4 0.95
Unknown 78 93 4
Age group, years
1e4 150 47.17
5e9 68 21.38
10e14 68 21.38
15e17 32 10.06
18e24 80 19.37 26 6.15
25e34 101 24.46 137 32.39
35e44 132 31.96 152 36.17
45e52* 100 24.21 107 25.30
*Percentage of respondents with valid answers to the question.
yNew Zealand European.
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Self-diagnosis of inﬂuenzapopulation-based sample during a pandemic. The like-
lihood of being seropositive was no different in those
who believed they had inﬂuenza from those who
believed they did not have inﬂuenza. This ﬁnding
applied to HCW as well as adults and children. Our study
showed that self-diagnosis in a NZ population lacks
sensitivity and speciﬁcity for diagnosing inﬂuenza. The
poor sensitivity may lead people with inﬂuenza to believe
that they are well and therefore to fail to take measures
to limit their contribution to inﬂuenza spread. The lack
of speciﬁcity may result in delayed medical treatment
when serious treatable illness is present.
18
Strengths and weaknesses of the study
Limitations of this study include the fact that some of the
participants who believed they had the ﬂu and yet were
seronegative for H1N1 may have had seasonal inﬂuenza
or other respiratory pathogens. However, H1N1 was the
dominant inﬂuenza strain in 2009, accounting for 77.6%
of inﬂuenza viruses that were sub-typed during the
year.
19 Further, the fact that seasonal inﬂuenza was
replaced very quickly by pandemic H1N1 reduces this
limitation to some extent. A small proportion of those
who were seropositive will have baseline immunity to
H1N1 acquired prior to 2009, although testing of stored
Table 3 Serological status according to diagnostic approach for people self-reporting having had inﬂuenza
Method of diagnosis n % Seropositive* 95% CI p Valuey
Adults (18+ years)z (n¼108)
Health professional 37 27.1% (7.9 to 46.3) 0.392
Self-diagnosis 61 17.7% (5.3 to 30.1)
Children (<18 years)x (n¼86)
Health professional 43 39.7% (18.4 to 61.1) 0.332
Self-diagnosis 34 25.2% (4.5 to 45.9)
Healthcare workers{ (n¼94)
Health professional 25 40.0% (21.1 to 61.3) 0.356
Self-diagnosis 67 29.9% (19.3 to 42.3)
*Weighted percentage.
yThe p value for healthcare workers is from Pearson’s c
2 test; p values for adults and children are from the Rao-Scott c
2 test.
z10 Adults from a community sample were missing information on the pathway of diagnosis.
x9 Children were missing information on the pathway of diagnosis.
{2 Healthcare workers were missing information on the pathway of diagnosis.
Table 4 Screening performance of inﬂuenza deﬁnitions for detecting seropositive status (sensitivity, speciﬁcity, PPV and
NPV)
Measure
NZ sentinel surveillance ILI
deﬁnition*
NZ Ministry of Health ILI
deﬁnitiony Self-reported ﬂu statusz
Point estimate (95% CI) Point estimate (95% CI) Point estimate (95% CI)
Adults (18+ years)x (n¼413)
Sensitivity 37.7 (25.5 to 50.0) 38.0 (25.6 to 50.4) 45.7 (33.0 to 58.3)
Speciﬁcity 60.5 (53.6 to 67.4) 67.2 (60.6 to 73.8) 58.1 (51.0 to 65.3)
PPV 21.6 (13.6 to 29.6) 25.1 (15.8 to 34.4) 24.1 (16.2 to 31.9)
NPV 77.1 (70.6 to 83.5) 79.0 (73.1 to 84.8) 78.7 (72.0 to 85.3)
Children (<18 years){ (n¼318)
Sensitivity 32.5 (21.0 to 44.0) 36.0 (24.5 to 47.6) 42.4 (30.0 to 54.9)
Speciﬁcity 68.4 (58.4 to 78.4) 57.2 (47.3 to 67.1) 52.6 (42.1 to 63.0)
PPV 43.4 (29.1 to 57.7) 38.6 (27.0 to 50.1) 40.9 (29.3 to 52.6)
NPV 57.6 (48.2 to 67.0) 54.5 (44.0 to 65.0) 54.1 (43.0 to 65.3)
Healthcare workers** (n¼423)
Sensitivity 32.5 (23.8 to 41.1) 30.7 (22.2 to 39.2) 48.2 (38.8 to 57.6)
Speciﬁcity 70.8 (65.7 to 75.9) 76.4 (71.6 to 81.2) 57.7 (51.9 to 63.4)
PPV 29.9 (21.9 to 37.9) 32.7 (23.8 to 41.6) 30.5 (23.6 to 37.3)
NPV 73.5 (68.5 to 78.6) 74.7 (69.8 to 79.5) 74.3 (68.6 to 80.1)
*Two or more symptoms from: fever, muscle ache and headache.
yFever, plus cough and/or sore throat.
zSelf-diagnosis, assisted-self-diagnosis or self-diagnosis by proxy.
xAdults: 16 ‘don’t know’ respondents on self-reported inﬂuenza status were excluded from analysis.
{Children: 21 ‘don’t know’ respondents on self-reported inﬂuenza status were excluded from analysis.
**Healthcare workers: 22 ‘don’t know’ respondents on self-reported inﬂuenza status and ﬁve respondents missing immunological status were
excluded from analysis.
ILI, inﬂuenza like illness; NPV, negative predictive value; NZ, New Zealand; PPV, positive predictive value.
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Self-diagnosis of inﬂuenzasera shows that the level of such infection is low, ranging
from 6.5% to 7.5% in the 20e59-year-old population.
11
Further, this survey was based on symptom recall rather
than symptom reports at the time of presentation.
Symptoms reported retrospectively may well not match
the actual symptoms experienced during the illness.
However, the pandemic was an unusual event of some
concern to the individual and recall bias tends to be
minimal in such situations. Furthermore, there is some
validity in focusing on recalled symptoms, because these
may reﬂect the participants’ enduring perceptions of
inﬂuenza, which may guide their behaviour in relation
to future episodes of ILI. The higher likelihood of
positive serology in those adults who consulted a health
professional may be related to greater severity of their
disease which this study does not capture. Also, it is likely
that a higher proportion of people than usual may have
consulted a healthcare provider due to the high media
attention given to ‘swine-ﬂu’. The ﬁndings of this study
might not be generalisable to other inﬂuenza viruses
causing seasonal and pandemic disease.
Strengths and weaknesses in relation to other studies
Other studies have attempted to understand how lay
people report ILI, but have not obtained medical or
laboratory conﬁrmation of the diagnosis as ours did.
20 21
In excess of nine H1N1 seroprevalence studies have
been carried out following the pandemic.
22 Almost
all used unlinked specimens and so were not able to
question participants about their symptom history.
23e26
Two studies in selected military populations collected
symptom data. One prospective study of Singaporean
military personnel tracked symptomatic illness during
the pandemic and found that less than a third of those
who were seropositive reported symptoms.
27 A small
cross-sectional study reported seroconversion following
an H1N1 outbreak in a Finnish military garrison, and
found that sensitivity for seropositivity was 50% on the
basis of self-reported upper respiratory tract infection
symptoms (ie, half of those with serological evidence of
infection reported a history of upper respiratory tract
infection symptoms).
28 This is comparable with the
sensitivities for the current dataset, which were 45.7%
and 48.2% for the community adults and the HCW
adults, respectively. Participants in this NZ seropreva-
lence survey were more likely to believe they had been
infected if they had symptoms commonly advertised by
public health campaigns as being linked with the ﬂu.
However, these symptom proﬁles were not signiﬁcantly
associated with seropositivity. This ﬁnding is consistent
with a recent systematic review of symptoms in volunteer
challenge studies, where nearly one in three participants
demonstrated no clinical symptoms of inﬂuenza despite
laboratory conﬁrmed infection.
29 The authors of that
study questioned whether naturally acquired inﬂuenza
might produce more marked symptoms. Our study
would appear to show that this is not the case, at least for
pandemic H1N1 inﬂuenza.
Table 5 Association between symptom proﬁles and self-reported ﬂu status and seropositive status
Self-report status Seropositive status
OR (95% CI) OR (95% CI)
NZ sentinel surveillance deﬁnitions*
Adults (18+ years)x
No or 1 symptom Reference group Reference group
2 or 3 symptoms 27.1 (13.6 to 53.6) 0.93 (0.5 to 1.7)
Children (<18 years){
No or 1 symptom Reference group Reference group
2 or 3 symptoms 21.5 (8.98 to 51.6) 1.04 (0.52 to 1.09)
Healthcare workers**
No or 1 symptom Reference group Reference group
2 or 3 symptoms 18.2 (10.3 to 32.1) 1.19 (0.75 to 1.9)
Ministry of Health (MoH) deﬁnitiony
Adults (18+ years)x
Met MoH deﬁnition 11.5 (6.1 to 21.8) 1.3 (0.7 to 2.3)
Did not meet deﬁnition Reference group Reference group
Children (<18 years){
Met MoH deﬁnition 9.5 (4.5 to 20) 0.8 (0.4 to 1.4)
Did not meet deﬁnition Reference group Reference group
Healthcare workers**
Met MoH deﬁnition 13.3 (7.4 to 23.9) 1.46 (0.9 to 2.4)
Did not meet deﬁnition Reference group Reference group
ORs and 95% CI derived from independent logistic regression models.
*Two or more symptoms from: fever, muscle ache and headache.
yFever, plus cough and/or sore throat.
zSelf-diagnosis, assisted-self-diagnosis or self-diagnosis by proxy.
xAdults: 16 ‘don’t know’ respondents on self-reported inﬂuenza status were excluded from analysis.
{Children: 21 ‘don’t know’ respondents on self-reported inﬂuenza status were excluded from analysis.
**Healthcare workers: 22 ‘don’t know’ respondents on self-reported inﬂuenza status and ﬁve respondents missing immunological status were
excluded from analysis.
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These study ﬁndings raise important questions for
pandemic control polices. On the positive side, they
show that the NZ public has absorbed a fairly coherent
ILI case deﬁnition that includes the symptoms
traditionally linked with inﬂuenza. Unfortunately, we
have demonstrated that this generic picture of ILI is
a poor predicator of inﬂuenza infection. The classic
symptoms of inﬂuenza are non-speciﬁc and accompany
other infections commonly seen during the inﬂuenza
season. A systematic review comparing inﬂuenza symp-
toms to independent criterion standards for inﬂuenza
highlighted that epidemiological data (for example,
reports of regional inﬂuenza patterns) were probably
more useful than clinical indicators for predicting
whether an individual had inﬂuenza.
30 In addition, daily
temperature measurement plus reporting of respiratory
symptoms resulted in reduced transmission of H1N1
virus.
27 It is also useful to note that HCW perform no
better than non-professionals: the PPV of an ILI diag-
nosis by a HCW was 30.1%. Interestingly, this value is
similar to the PPV of clinical diagnosis by a GP for
patients presenting to sentinel sites over the same period
in 2009 (31.3% based on 624 viruses from 1993 swabs
received).
19 These ﬁndings reinforce public health
advice during the pandemic that patients should seek
medical care on the basis of disease severity rather than
for the purpose of diagnosis.
Further research
Given the importance of self-diagnosis to containment
and mitigation measures, further investigations around
the low accuracy of self-diagnosis would be useful.
Priorities for such research could include more in-depth
qualitative investigation of patient reports of inﬂuenza,
prospective exploration of patient self-diagnosis at the
time of respiratory infection, and variations in self-diag-
nosis by ethnicity, socioeconomic status and age, partic-
ularly given the differential distribution of respiratory
illness across these groups (our sample was not sufﬁ-
ciently large to enable these analyses).
11 The presenting
symptoms of inﬂuenza may vary depending on the type
of inﬂuenza responsible. In Singapore, H1N1 and
seasonal inﬂuenza had different symptom proﬁles, with
fever and runny nose being more common among
seasonal inﬂuenza cases
31 and the prevalence of speciﬁc
symptoms among H1N1 cases also varied between
studies,
32e34 so further exploration is warranted.
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